MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
FONAR Corporation P/E Ratio 2011-2025 | FONR
Annual P/E Ratio FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.85 | 8.92 | 19.2 | 10.1 | 7.69 | 8.69 | 9.14 | 4.98 | 6.54 | 4.09 | 3.51 | 3.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.2 | 3.3 | 7.75 |
P/E Ratio of other stocks in the Medical devices industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
0.0719 | - | - | $ 17.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
-9.58 | $ 20.95 | -0.1 % | $ 2.99 B | USA |
 |
Acutus Medical
AFIB
|
-0.0641 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-2.07 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-50 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-45.2 | - | 24.59 % | $ 44.8 M |  China |
 |
Cognyte Software Ltd.
CGNT
|
-54.8 | $ 9.28 | -0.32 % | $ 666 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
-2.44 | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
84 | $ 95.79 | -0.24 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-2.84 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-10.9 | $ 303.53 | -0.15 % | $ 8.56 B | USA |
 |
Apollo Endosurgery
APEN
|
-10.1 | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-0.25 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-15.9 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-0.813 | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
-0.707 | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
23.2 | $ 28.33 | -0.6 % | $ 240 M | USA |
 |
Bruker Corporation
BRKR
|
0.000061 | $ 48.37 | 0.74 % | $ 7.21 K | USA |
 |
Abbott Laboratories
ABT
|
17.5 | $ 124.66 | -0.14 % | $ 217 B | USA |
 |
Eargo
EAR
|
-0.108 | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-3.16 | $ 3.25 | -4.41 % | $ 121 M |  France |
 |
CryoLife, Inc.
CRY
|
-54.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0578 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-15.7 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-875 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-31 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-10.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-27.2 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
7.91 | $ 14.81 | 1.3 % | $ 1.17 B | Israel |
 |
IRIDEX Corporation
IRIX
|
-5.02 | $ 1.17 | -4.88 % | $ 18.9 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 97.65 | 0.21 % | $ 1.24 B | USA |
 |
Dynatronics Corporation
DYNT
|
-0.179 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
-10.2 | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
36.1 | $ 62.29 | -0.93 % | $ 3.38 B |  Britain |
|
LENSAR
LNSR
|
-4.14 | $ 11.93 | -0.21 % | $ 137 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.0096 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
33.1 | $ 158.32 | -0.03 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
-0.248 | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
-101 | $ 0.81 | -1.31 % | $ 83.2 M | USA |
 |
Avinger
AVGR
|
-0.142 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-24.6 | $ 13.56 | -3.28 % | $ 366 M | USA |
 |
AxoGen
AXGN
|
-86.3 | $ 33.15 | 1.07 % | $ 1.47 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-47.3 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-0.235 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
14.6 | $ 41.41 | 1.57 % | $ 1.28 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-15.6 | $ 17.7 | 2.08 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
111 | $ 88.34 | -0.08 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-271 | $ 12.58 | -0.32 % | $ 969 M | USA |
 |
Aziyo Biologics
AZYO
|
-0.714 | - | 1.37 % | $ 20.5 M | USA |